<DOC>
	<DOCNO>NCT00106002</DOCNO>
	<brief_summary>The purpose study determine whether pemetrexed help patient metastatic ( cancer spread part body ) breast cancer , determine side effect may associate drug , determine much pemetrexed give patient , collect DNA future research regard metastatic breast cancer . The collection DNA optional patient .</brief_summary>
	<brief_title>Pemetrexed First Treatment Advanced Metastatic Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Ductal</mesh_term>
	<mesh_term>Breast Neoplasms , Male</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Must diagnose either advanced metastatic breast cancer . Chemotherapy give advance metastatic breast cancer . The diagnosis advance metastatic breast cancer make least 12 month chemotherapy give breast surgery . Able carry work light nature ( example , light housework , office work ) . Must least 18 year old . Have receive prior bone marrow peripheral stem cell transplantation . Have receive prior chemotherapy metastatic breast cancer . Are currently pregnant breastfeeding . Have active infection doctor decides affect safety . Are unable take folic acid vitamin B12 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>